Drug
Nadofaragene Firadenovec-vncg
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Micturition Urgency | 28 | 105.5 | 111.8 | signal |
| 2 | Incontinence | 8 | 32.2 | 32.7 | signal |
| 3 | Disease Recurrence | 36 | 32.2 | 34.6 | signal |
| 4 | Incorrect Product Administration Duration | 12 | 25.2 | 25.8 | signal |
| 5 | Haematuria | 19 | 23.6 | 24.5 | signal |
| 6 | Blood Urine Present | 9 | 20.1 | 20.5 | signal |